Frankly Speaking About Family Medicine Pri-Med

Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-207
Overview: Data are limited regarding statin therapy for primary prevention of atherosclerotic cardiovascular disease in adults 75 years and older. During this episode we will review recent studies on the use of statins in elderly patients and discuss how to consider this data in your clinical practice.
Guest: Robert Baldor, MD, FAAFP
Music Credit: Richard Onorato

Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-coding-update
Overview: This session will overview the new 2021 changes for outpatient E&M billing documentation requirements.
Guest: Robert Baldor, MD, FAAFP
Music Credit: Richard Onorato

Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-206
Overview: The evidence of the impact of obesity and sedentary lifestyles on health and disease states is well established. Finding and applying strategies to assist people with the necessary behavior changes is a monumental task, but for Americans who are at lower income levels and in traditionally underserved populations, the evidence on what is effective is tragically lacking. The social determinants of health (SDOH) impact all aspects of care delivery, from access to care, to knowing what really works. Join us as we discuss a recent randomized controlled trial that evaluated a strategy that demonstrated weight loss in underserved populations, and may have promise to aid in this important aspect of care.
Guest: Susan Feeney, DNP, FNP-BC, NP-C
Music Credit: Richard Onorato

Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-covid-immunization-update
Overview: This podcast will give an overview of the two mRNA vaccines granted emergency use authorization in the US including their efficacy and side effect profile.
Guest: Alan Ehrlich, MD
Music Credit: Richard Onorato

Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-205
Overview: In patients with new-onset atrial fibrillation, the decision to aim for rate control versus rhythm control is controversial. Older data suggested rhythm control did not result in better outcomes, but advances in medications and techniques have led to a new trial to evaluate this question.
Guest: Alan Ehrlich, MD
Music Credit: Richard Onorato

Credits: 0.25 AMA PRA Category 1 Credits™
Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-204
Overview: The American Diabetes Association (ADA) has recently updated their guidelines for pharmacologic management of T2DM which addresses patients with various co-morbid conditions. This episode will overview these guidelines to help primary care clinicians hone treatment of their patients with T2DM.
Guest: Robert Baldor, MD, FAAFP
Music Credit: Richard Onorato